Patents Assigned to Intermune, Inc.
  • Combination therapy of gamma-interferon and B-cell specific antibodies
    Publication number: 20050058644
    Abstract: A combination therapy is provided of IFN-? and therapeutic antibodies that recognize determinants on hyperproliferative B lineage cells. The targeted cells are contacted with these agents either locally or systematically, usually systematically. The subject methods provide a means for therapeutic treatment and investigation of hyperproliferative disorders.
    Type: Application
    Filed: December 8, 2003
    Publication date: March 17, 2005
    Applicant: INTERMUNE, INC.
    Inventor: Edgar Engleman